NEW YORK (GenomeWeb News) – Agilent Technologies has launched an investigation into activities of certain of its employees in China for possible infractions of US law, the company said in its Form 10-Q.

The company also said that a total of 700 employees are expected to be laid off from as a result of its restructuring and manufacturing streamlining efforts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.